FindMyKOL

Daniel Knoch, MD

Basic profile

University of Wisconsin System

ORCIDNone on fileNPI↗
✓ Itemized record
RegionMadison, WI · MidwestSpecialtyOphthalmologyFocusOphthalmology
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Daniel Knoch is an Ophthalmology physician affiliated with University of Wisconsin System. OpenAlex indexes 10 publications with 239 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Publications indexed by OpenAlex. Counts exclude supporting files.

239citations

Citations across these publications.

4h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    77.8%
    Prostaglandin Analog52.7%
    Latanoprost84%Travoprost16%
    Part D<11 patients
    Lymphocyte Function-Associated Antigen-1 Antagonist9.6%
    Xiidra100%
    Part D<11 patients

    + 2 more classes in this area

  • Cardiovascular

    13.8%
    Beta blocker13.8%
    Timolol Maleate100%
    Part D≥14 patients
  • Cancer & immunology

    8.4%
    Calcineurin inhibitor8.4%
    Cyclosporine100%
    Part D<11 patients
Where care is delivered (Part B), 202312.1% facility · 87.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”